BlackRock Institutional Trust’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

BlackRock Institutional Trust’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.81M	Buy	501,502 +2,681	+0.5%	+$14.7K	﹤0.01%	2940
2016 Q3	$2.77M	Sell	498,821 -5,881	-1%	-$38.9K	﹤0.01%	2928
2016 Q2	$3.54M	Sell	504,702 -41,487	-8%	-$292K	﹤0.01%	2824
2016 Q1	$3.61M	Buy	546,189 +82,052	+18%	+$604K	﹤0.01%	2806
2015 Q4	$4.78M	Buy	464,137 +10,606	+2%	+$123K	﹤0.01%	2757
2015 Q3	$5.34M	Buy	453,531 +75,339	+20%	+$833K	﹤0.01%	2678
2015 Q2	$3.46M	Buy	378,192 +3,460	+0.9%	+$26.1K	﹤0.01%	2895
2015 Q1	$2.33M	Sell	374,732 -37,399	-9%	-$231K	﹤0.01%	3049
2014 Q4	$2.31M	Sell	412,131 -2,191	-0.5%	-$12.8K	﹤0.01%	3041
2014 Q3	$2.44M	Sell	414,322 -20,897	-5%	-$127K	﹤0.01%	2989
2014 Q2	$2.98M	Sell	435,219 -8,540	-2%	-$57.1K	﹤0.01%	3015
2014 Q1	$3.2M	Buy	443,759 +96,395	+28%	+$666K	﹤0.01%	2955
2013 Q4	$2.3M	Buy	347,364 +65,329	+23%	+$445K	﹤0.01%	3102
2013 Q3	$2.05M	Buy	+282,035	New	+$1.9M	﹤0.01%	3123

Other funds holding JNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

BlackRock Institutional Trust's JNP Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Juniper Pharmaceuticals, Inc. Common Stock (JNP) stake by 0.54% in Q4 2016, buying an estimated $14.7K and bringing the position to 501,502 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

BlackRock Institutional Trust first reported a position in JNP in Q3 2013 and has held it in 14 quarters since. The position peaked at $5.34M in Q3 2015. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

BlackRock Institutional Trust held 501,502 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $2.81M as of Q4 2016.
BlackRock Institutional Trust bought 2,681 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2016, an estimated $14.7K.
Juniper Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2940 holding.
BlackRock Institutional Trust first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and has held it in 14 quarters since.
BlackRock Institutional Trust's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $5.34M in Q3 2015.
40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.